/
RADX
$4.13+$0.11 (+2.74%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$31.7M
8M shares
52-week range
$3.62 – $16.25
4% from low
Exchange
NASDAQ
ADRC
Borrow rate
39.31%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-13.54
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Revenue | $8.8K | $292.4K | $299.2K | $3.6M |
| Cost of revenue | $0 | $0 | $0 | $3.6M |
| Gross profit | $8.8K | $292.4K | $299.2K | $39.3K |
| Gross margin | 100.0% | 100.0% | 100.0% | 1.1% |
| R&D | $4.1M | $13.8M | $17.6M | $27.5M |
| Operating income | −$19.9M | −$34.5M | −$36.6M | −$38.2M |
| EBITDA | −$18.0M | −$31.2M | −$44.1M | −$38.2M |
| Net income | −$30.3M | −$34.6M | −$47.9M | −$38.3M |
| Net margin | -343550.9% | -11838.6% | -16024.3% | -1055.3% |
| EPS (diluted) | -29.76 | -33.00 | -36.00 | -5.28 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3M | $-4.57 | $-7.87–$-0.03 | 2 |
| 2027 | $3M | $-5.56 | $-11.08–$-0.05 | 1 |
| 2028 | $27M | $-4.39 | $-4.39–$-4.39 | 1 |
| 2029 | $120M | $-0.31 | $-0.31–$-0.31 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Radiopharm Theranostics Limited American Depositary Shares
Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
www.radiopharmtheranostics.com- Employees
- 14
- IPO / List date
- Nov 27, 2024
Held by traders on TradeandTell
No one on the platform currently holds RADX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in RADX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded RADX yet.
